Elbit Imaging Ltd. (“EI” or the “Company”) (TASE:EMITF) (NASDAQ:EMITF) announced today, further to the announcement dated September 25, 2015, with respect to the filing of a Motion for approval of a derivative claim against the Company and its directors (the “Motion” and the “Derivative claim,” respectively) that mutual request to dismiss the Motion has been submitted to the court upon both sides consent.

Both the applicant and the respondents have agreed to avoid taking any further legal procedures with respect to any actions taken as part of the Company and its subsidiaries' activity.

The Motion dismissal is subject to the court decision.

About Elbit Imaging Ltd.

Elbit Imaging Ltd. operates in the following principal fields of business: (i) Commercial centers - initiation, construction, and sale of commercial centers and other mixed-use property projects, predominantly in the retail sector, located in Central and Eastern Europe. In certain circumstances and depending on market conditions, the Group operates and manages commercial centers prior to their sale. (ii)  Hotels - hotels operation and management. (iii) Medical industries and devices - (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment, and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine. (iv) Residential projects - initiation, construction and sale of residential units or plots designated for residential located primarily in India.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Any forward-looking statements in our releases include statements regarding the intent, belief or current expectations of Elbit Imaging Ltd. and our management about our business, financial condition, results of operations, and its relationship with its employees and the condition of our properties. Words such as “believe,” "would," “expect,” “intend,” “estimate” and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors including, without limitation, the factors set forth in our filings with the Securities and Exchange Commission including, without limitation, Item 3.D of our annual report on Form 20-F for the fiscal year ended December 31, 2014, under the caption “Risk Factors.” Any forward-looking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forward-looking statements do not purport to be predictions of future events or circumstances, and therefore, there can be no assurance that any forward-looking statement contained in our releases will prove to be accurate. We undertake no obligation to update or revise any forward-looking statements.

For Further Information:
Company Contact  
Ron Hadassi      
Chairman of the Board of Directors       
Tel: +972-3-608-6048
Fax: +972-3-608-6050     
ron@elbitimaging.com     
Elbit Imaging (CE) (USOTC:EMITF)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Elbit Imaging (CE) Charts.
Elbit Imaging (CE) (USOTC:EMITF)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Elbit Imaging (CE) Charts.